Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.
about
Infectious complications of immune modulatory agents.Human leukocyte antigens and alloimmunization in heart transplantation: an open debate.Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.Renal protection strategies after heart transplantation.
P2860
Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.
@en
type
label
Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.
@en
prefLabel
Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.
@en
P2093
P2860
P356
P1476
Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients.
@en
P2093
Christopher R Ensor
Michael A Shullo
William D Cahoon
P2860
P304
344-9; quiz 350
P356
10.7182/PIT2012241
P577
2012-12-01T00:00:00Z